Risk factors for mortality in patients treated with ceftazidime-avibactam for ceftazidime-avibactam susceptible carbapenem-resistant Klebsiella pneumoniae bacteremia

Background: Ceftazidime-avibactam (CZA) is the preferred treatment for infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKP). This study aimed to investigate the prognostic factors of 28-day mortality and 14-day clinical failure in patients treated with CZA for CZA-susceptible CRKP...

Cijeli opis

Bibliografski detalji

Glavni autori:	Yi-Tsung Lin, Shih-Neng Lin, Chien Chuang, Szu-Yu Liu, Yu-Chien Ho, Chih-Han Juan, Hsiang-Ling Ho, Sheng-Hua Chou
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2025-09-01
Serija:	Journal of Infection and Public Health
Teme:	Ceftazidime-avibactam Bacteremia Mortality Risk factors
Online pristup:	http://www.sciencedirect.com/science/article/pii/S1876034125001856
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!